Symptoms and Signs of Penis Infection Caused by an STI
HIV AIDS Control Tips: Different Types Of HIV Tests, And Their Importance In Managing Symptoms
HIV tests are broadly categorized into screening, confirmation, or treatment monitoring. All tests for HIV screening and confirmation of diagnosis should include pretest counseling before performing the tests and post-test counseling before disclosing the results. It may be necessary to refer the patient to appropriate services such as HIV specialists and Integrated Counseling and Testing Centers (ICTC) following NACO guidelines.
We spoke to Dr. Niranjan Patil, AVP, and Scientific Business Head - Infectious Diseases, Microbiology & Molecular Biology- Head & Biosafety officer, Metropolis Healthcare Limited, to understand more about HIV screening and different ways in which this condition can be managed.
Tests for HIV screeningIn India, HIV screening is conducted following the NACO guidelines for HIV testing. Serological tests, such as HIV1 and 2 antibody tests, can be performed. For individuals aged over 18 years who are clinically asymptomatic, the sample should react to HIV antibodies with three different kits (Strategy III) as per NACO guidelines. Antibody-based tests can take various forms, such as ELISA, CMIA, CLIA, ELFA, lateral flow immunochromatography-based rapid tests, immunofiltration, etc.
Currently, 4th generation assays based on antigen-antibody interactions can be performed, reducing the window period for detection. The window period for antibody-based tests is the time gap between the entry of the HIV virus into the human body and the appearance of detectable antibodies in human serum or plasma samples. This period may vary from 6 weeks to 6 months from person to person, depending on various factors. During the window period, HIV antibody tests may yield false-negative or non-reactive results. HIV antigen-based or HIV PCR-based tests may be recommended for HIV diagnosis during this window period for antibody-based tests.
For newborn infants and children under 18 months of age, maternally acquired antibodies may interfere with antibody-based serological screening tests for HIV. It is recommended to perform nucleic acid-based qualitative tests such as HIV1 proviral DNA PCR, HIV2 RNA PCR, or HIV p24 antigen tests. NACO recommends the use of a dried blood sample to perform DNA PCR tests between 6 weeks to 18 months of age for the diagnosis of HIV in infants.
HIV Tests For ConfirmationAn HIV 1 and 2 western blot test may be performed, which looks for various proteins of HIV1 and 2. However, it has a longer window period of detection compared to the screening tests and is recommended to be performed for confirmation of the screening results obtained from the antibody-based tests.
Alternatively, HIV testing can be conducted using nucleic acid-based tests such as HIV1 RNA PCR and HIV2 RNA PCR.
HIV tests for treatment monitoring
For known HIV-positive patients who are consuming HIV anti-retroviral agents, viral load tests such as HIV-1 and HIV-2 quantitative viral load tests, which look for HIV RNA viral copies, are used to monitor the response to treatment. These viral load-based tests may be performed at 6-month intervals to assess prognosis. Additionally, tests such as CD4 counts may be used as an additional parameter to monitor the response to anti-viral treatment.
Apart from these, there are tests meant for the detection of resistance to anti-retroviral agents referred to as HIV drug resistance tests, which may be genotypic or phenotypic. Generally, HIV genotypic tests involve DNA/RNA sequencing, which includes performing PCR followed by sequencing of the nucleic acid. This is followed by comparing the sequence obtained with a standard database using sophisticated software algorithms. These HIV drug resistance tests help the HIV specialist doctor choose and alter anti-HIV medications during the course of treatment for an individual patient.
Metropolis has been a pioneer in HIV testing in the private diagnostics sector for more than three and a half decades now and has been an active partner with NACO and the Government of India for HIV viral load testing.
HIV And AIDS News
Aug. 22, 2023 — A team of researchers successfully tested a new antifungal therapy to treat fungal ...
Aug. 17, 2023 — A single injection of a novel CRISPR gene-editing treatment safely and efficiently removes SIV -- a virus related to the AIDS-causing agent HIV -- from the genomes of non-human primates, scientists ...
Aug. 10, 2023 — Researchers created a germ-free mouse model to evaluate the role of the microbiome in the infection, replication, and pathogenesis of HIV and the Epstein-Barr virus, the virus that can cause ...
Aug. 10, 2023 — A study has identified a new pathway that human immune deficiency virus (HIV) uses to enter the nucleus of a healthy cell, where it can then replicate and go on to invade other ...
Aug. 8, 2023 — Some HIV-1 carriers who have received an early antiretroviral treatment during several years are able to control the virus for a long term after treatment interruption. However, the mechanisms ...
Aug. 2, 2023 — A study on almost four thousand people of African descent has identified a gene that acts as natural defense against HIV by limiting its replication in certain white blood cells. This research paves ...
July 28, 2023 — Scientists appear to have discovered a way to produce a true structure of the rare but naturally-occurring anti-HIV compound Lancilactone C from start to finish. The domino-like reaction enables the ...
July 26, 2023 — The results of a novel study has revealed exciting findings in the pursuit of an HIV ...
July 22, 2023 — Researchers have discovered the molecular mechanisms by which the human immunodeficiency virus (HIV) becomes resistant to Dolutegravir, one of the most effective, clinically used antiviral drugs for ...
July 4, 2023 — Global efforts to reduce infectious disease rates must have a greater focus on older children and adolescents after a shift in disease burden onto this demographic, according to a new ...
June 27, 2023 — A milliliter of blood contains about 15 individual drops. For a person with human immunodeficiency virus (HIV), each drop of blood could contain anywhere from fewer than 20 copies of the virus to ...
June 22, 2023 — Just as space holds infinite mysteries, when we zoom in at the level of biomolecules (one trillion times smaller than a meter), there is still so much to learn. Scientists are studying the ...
May 30, 2023 — Scientists have spent years trying to develop an effective HIV vaccine, but none have proven successful. Based on findings from a recently published study, a research team may have put science one ...
May 25, 2023 — New animal research is helping explain why at least five people have become HIV-free after receiving a stem cell transplant, and may bring scientists closer to developing what they hope will be a ...
May 9, 2023 — New research found that people living with HIV that have had pulmonary tuberculosis had broader and more potent HIV antibody responses and differences in HIV sequences predicted to be antibody ...
May 2, 2023 — Gene-editing therapy aimed at two targets -- HIV-1, the virus that causes AIDS, and CCR5, the co-receptor that helps the virus get into cells -- can effectively eliminate HIV infection, new research ...
Mar. 27, 2023 — To develop treatments that may one day entirely rid the body of HIV infection, scientists have long sought to identify all of the places that the virus can hide its genetic code. Now, in a study ...
Mar. 24, 2023 — MitoQ, a mitochondrial antioxidant that is available to the public as a diet supplement, was found in a mouse study to reverse the detrimental effects that HIV and antiretroviral therapy (ART) have ...
Mar. 16, 2023 — The human immunodeficiency virus HIV-1 is able to infect various tissues in humans. Once inside the cells, the virus integrates its genome into the cellular genome and establishes persistent ...
Mar. 9, 2023 — Researchers have examined how patient characteristics and COVID-19 infection may affect the antibody responses of people with HIV -- including responses against SARS-CoV-2 proteins as well as ...
Tuesday, August 22, 2023
Thursday, August 17, 2023
Thursday, August 10, 2023
Tuesday, August 8, 2023
Wednesday, August 2, 2023
Friday, July 28, 2023
Wednesday, July 26, 2023
Saturday, July 22, 2023
Tuesday, July 4, 2023
Tuesday, June 27, 2023
Thursday, June 22, 2023
Tuesday, May 30, 2023
Thursday, May 25, 2023
Tuesday, May 9, 2023
Tuesday, May 2, 2023
Monday, March 27, 2023
Friday, March 24, 2023
Thursday, March 16, 2023
Thursday, March 9, 2023
Tuesday, February 28, 2023
Friday, February 24, 2023
Tuesday, January 31, 2023
Monday, January 30, 2023
Wednesday, January 18, 2023
Tuesday, January 17, 2023
Tuesday, January 10, 2023
Monday, January 2, 2023
Friday, December 9, 2022
Tuesday, December 6, 2022
Friday, December 2, 2022
Monday, November 28, 2022
Tuesday, November 22, 2022
Monday, November 14, 2022
Thursday, November 10, 2022
Tuesday, November 8, 2022
Monday, November 7, 2022
Friday, November 4, 2022
Tuesday, November 1, 2022
Friday, October 28, 2022
Tuesday, October 25, 2022
Friday, October 21, 2022
Monday, October 17, 2022
Thursday, October 13, 2022
Wednesday, October 12, 2022
Tuesday, October 4, 2022
Monday, October 3, 2022
Friday, September 30, 2022
Thursday, September 29, 2022
Monday, September 26, 2022
Friday, September 23, 2022
Wednesday, September 21, 2022
Thursday, September 15, 2022
Thursday, September 8, 2022
Thursday, September 1, 2022
Friday, August 26, 2022
Wednesday, August 24, 2022
Wednesday, August 17, 2022
Wednesday, August 10, 2022
Friday, August 5, 2022
Tuesday, August 2, 2022
Wednesday, July 27, 2022
Monday, July 25, 2022
Friday, July 22, 2022
Thursday, July 21, 2022
Wednesday, July 20, 2022
Tuesday, July 19, 2022
Friday, July 15, 2022
Thursday, July 14, 2022
Friday, July 8, 2022
Wednesday, July 6, 2022
Friday, July 1, 2022
Thursday, June 30, 2022
Wednesday, June 29, 2022
Tuesday, June 28, 2022
Monday, June 27, 2022
Tuesday, June 14, 2022
Tuesday, June 7, 2022
Wednesday, June 1, 2022
Wednesday, May 25, 2022
Tuesday, May 17, 2022
Monday, May 16, 2022
Thursday, May 12, 2022
Wednesday, May 11, 2022
Tuesday, May 10, 2022
Monday, May 9, 2022
Tuesday, May 3, 2022
Wednesday, April 20, 2022
Thursday, April 14, 2022
Monday, April 11, 2022
Immigration Federal Privacy Policy May Have Impacted HIV Status Among Black American Women
December 19, 2023
Before January 2010, foreign nationals with an HIV positive test were banned to enter and stay in the United States.
A recent interview revealed that Department of Homeland Security (DHS) officers upheld a dangerous federal privacy policy that may have impacted the HIV status of many African American women and children because of marriages to African men.
The Center for Immigration Studies interviewed Richard Lee, a retired DHS adjudicator from Charleston, South Carolina. He is no stranger to sharing his journey into the hidden corners of the American immigration system.
As the author of After the Border: 42 Eye-Opening, Shocking, Crazy, Happy & Fun Stories, Lee unravels "often obscured" narratives, especially those that "employ fraudulent marriages as a means to secure entry into the United States." Among other stories, Lee encountered African men during the adjudication process who did not disclose to their African-American wives that they were HIV positive.
"DHS had ruled that privacy (for the HIV-carrying male alien) was regarded as more important than the health of: 1) the woman involved, usually a Black U.S. Citizen; 2) any babies born to that couple; and 3) by extension, the public health of Americans generally," the report found based on Lee's testimony.
According to Lee, from 2003 to 2008, immigrants seeking entry in the U.S. Were required to submit proof of a negative HIV test. A positive result, on the other hand, "could bar the applicant" from entering and residing in the country. But immigrants were able to "waive that HIV status" through the United States Immigration and Naturalization Service, which was dissolved in 2003. Most of the petitions were approved.
Lee said that he and his fellow officers were forbidden to tell the wife of the husband's health condition. This was especially enforced in Atlanta, where he witnessed several such cases a week. In essence, the system essentially found "immigration-related spouse-deception" permissible, the Center for Immigration Studies noted.
Despite these orders, some officers tried to alert the family indirectly without completely dishonoring the federal privacy policy. According to Lee—
"I had a West African male come into the immigration office. As I reviewed his case and started the adjudication process, I looked at his medical records … every applicant who comes into the office must submit an I-693 medical exam for adjustment of status. On that medical exam, they must list any medical conditions they have…"
"Some of the standard questions that we asked were discussed with the [other] immigration officers. We frequently asked, 'Hey, are you guys planning on having children?' And inevitably, the African American woman almost always said, 'Yes, we're planning on having kids.' The West African man would always say, 'No, I'm not planning on having kids because of HIV.' I separated the husband and wife during the interview. … And I would always ask the West African man … 'Have you told your spouse that you have HIV?' All the time, the men would respond, 'No, I have not told her.'"
During that time, most experts assumed that more than 90% of HIV in African adults resulted from heterosexual transmission. Meanwhile, as of December 31, 2000, 774,467 persons had been reported with AIDS in the United States, the CDC reported.
Of those individuals, 448,060 of these had died, and 3,542 persons had "unknown vital status." Of the number of persons living with AIDS (322,865), 79% were men, 61% were black or Hispanic, and 41% were infected through male-to-male sex.
In January 2010, the ban on HIV-positive foreign nationals ended and stopped being an automatic ground for inadmissibility.
Comments
Post a Comment